Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

SHA:600222 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,666	2,823	3,429	3,544	5,056	2,735
Market Cap Growth	31.85%	-17.66%	-3.25%	-29.90%	84.84%	9.21%
Enterprise Value	4,652	3,456	3,965	3,814	5,742	3,210
Last Close Price	6.63	5.09	6.09	6.33	8.91	4.96
PE Ratio	84.89	55.88	78.72	-	843.33	93.55
PS Ratio	2.06	1.45	1.66	1.81	3.15	1.93
PB Ratio	2.21	1.74	2.11	2.20	2.84	1.79
P/TBV Ratio	2.90	2.28	2.77	2.87	3.83	2.47
P/FCF Ratio	-	-	5673.80	-	83.46	3529.88
P/OCF Ratio	-	-	78.40	-	50.74	37.25
EV/Sales Ratio	2.62	1.78	1.92	1.95	3.58	2.27
EV/EBITDA Ratio	33.92	27.17	31.16	96.86	33.91	27.29
EV/EBIT Ratio	63.07	45.53	52.21	-	45.81	42.12
EV/FCF Ratio	-48.54	-	6560.68	-	94.77	4142.80
Debt / Equity Ratio	0.71	0.63	0.48	0.41	0.69	0.87
Debt / EBITDA Ratio	8.58	7.30	5.42	12.08	6.71	11.26
Debt / FCF Ratio	-	-	1290.72	-	20.22	1709.07
Asset Turnover	0.49	0.55	0.58	0.53	0.45	0.45
Inventory Turnover	2.78	3.50	3.33	3.59	3.14	3.23
Quick Ratio	0.92	0.80	0.88	0.86	0.89	0.97
Current Ratio	1.29	1.06	1.21	1.18	1.18	1.25
Return on Equity (ROE)	3.08%	3.29%	2.77%	-4.47%	0.41%	1.86%
Return on Assets (ROA)	1.28%	1.34%	1.32%	-0.13%	2.18%	1.51%
Return on Capital (ROIC)	1.72%	1.88%	2.03%	-0.19%	2.67%	1.75%
Return on Capital Employed (ROCE)	3.60%	4.50%	3.90%	-	5.90%	4.00%
Earnings Yield	1.18%	1.79%	1.27%	-2.04%	0.12%	1.07%
FCF Yield	-2.61%	-2.72%	0.02%	-5.39%	1.20%	0.03%
Dividend Yield	0.42%	0.55%	0.29%	-	0.11%	0.32%
Payout Ratio	161.60%	136.70%	115.18%	-	1410.34%	223.89%
Buyback Yield / Dilution	0.87%	1.12%	-0.07%	-0.36%	-2.52%	1.68%
Total Shareholder Return	1.29%	1.67%	0.22%	-0.36%	-2.40%	2.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.